Regeneron Pharmaceuticals (REGN) Return on Equity [ROE] (2010 - 2026)
Regeneron Pharmaceuticals (REGN) reported Return on Equity [ROE] of 13.71% for Q2 2026, down 1.32 percentage points from 15.03% a year earlier and down 0.40 percentage points from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Return on Equity [ROE] (2010 - 2026) Analysis & Trends
For FY2025, Regeneron Pharmaceuticals posted Return on Equity [ROE] of 14.87%, down 1.09 percentage points from FY2024.
- Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -16.91 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 15.95% in FY2024 (-0.31 pp), 16.26% in FY2023 (-4.68 pp), 20.94% in FY2022 (-33.27 pp) and 54.21% in FY2021 (+22.44 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q1 2015.
- Year over year, Return on Equity [ROE] has now declined in each of the last five quarters, with an average year-over-year change of -0.59 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 11.61 percentage points); the low point was Q4 2022 (a drop of 25.16 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 14.11% (Q1 2026), 14.48% (Q4 2025) and 15.04% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.97% |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 13.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.71% |
| Mar 31, 2026 | 14.11% |
| Dec 31, 2025 | 14.48% |
| Sep 30, 2025 | 15.04% |
| Jun 30, 2025 | 15.03% |
| Mar 31, 2025 | 15.32% |
| Dec 31, 2024 | 15.04% |
| Sep 30, 2024 | 16.18% |
| Jun 30, 2024 | 15.66% |
| Mar 31, 2024 | 14.57% |
| Dec 31, 2023 | 15.54% |
| Sep 30, 2023 | 16.32% |
| Jun 30, 2023 | 18.10% |
| Mar 31, 2023 | 18.12% |
| Dec 31, 2022 | 19.67% |
| Sep 30, 2022 | 25.50% |
| Jun 30, 2022 | 28.01% |
| Mar 31, 2022 | 41.02% |
| Dec 31, 2021 | 44.83% |
| Sep 30, 2021 | 43.20% |
API Access
Regeneron Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();